HIV Prevention Trials Network

Studies

HPTN 035

Phase II/IIb Safety and Effectiveness Study of the Vaginal Microbicides BufferGel and 0.5% PRO2000/5 Gel (P) for the Prevention of HIV Infection in Women

 

Questions & Answers

Q & A Categories

Recent Questions & Answers

 

 

 
Site Map | HPTN Disclaimer | Webmaster | ©2008 Family Health International